par C831 Pill - green capsule/oblong, 24mm
Pill with imprint par C831 is Green, Capsule/Oblong and has been identified as Diltiazem Hydrochloride Extended-Release 240 mg. It is supplied by AvKare Inc.
Diltiazem is used in the treatment of Atrial Fibrillation; Atrial Flutter; Heart Failure; Angina Pectoris Prophylaxis; High Blood Pressure and belongs to the drug classes calcium channel blockers, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem 240 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for par C831

Diltiazem Hydrochloride Extended-Release
- Imprint
- par C831
- Strength
- 240 mg
- Color
- Green
- Size
- 24.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Calcium channel blockers, Group IV antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AvKare Inc.
- National Drug Code (NDC)
- 42291-0186 (Discontinued)
- Inactive Ingredients
-
ammonio methacrylate copolymer type A,
ammonio methacrylate copolymer type B,
ammonia,
gelatin,
hydroxypropyl cellulose (type l),
propylene glycol,
shellac,
sodium lauryl sulfate,
sucrose,
magnesium silicate,
titanium dioxide,
triethyl citrate,
ferrosoferric oxide,
D&C Yellow No. 10,
FD&C Green No. 3
Note: Inactive ingredients may vary.
More about diltiazem
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (188)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: calcium channel blockers
- Breastfeeding
Patient resources
Other brands
Cardizem, Cartia XT, Dilt-XR, Tiazac, ... +5 more
Professional resources
- Diltiazem Hydrochloride monograph
- Diltiazem (FDA)
- Diltiazem CD (FDA)
- Diltiazem Extended Release Tablets (FDA)
- Diltiazem Injection (FDA)
- Diltiazem Tablets (FDA)
Other brands
Cardizem, Cartia XT, Tiadylt ER, Dilt-XR, ... +6 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.